ABSTRACTS

Abstract submission is now closed.

The Scientific and Organising Committee thanks all those who have submitted an abstract for the congress.

Those who have submitted an abstract will be notified of the outcome following the review of all abstracts.

Please contact the Congress Secretariat at emec@epilepsycongress.org with any queries.

  1. Abstracts must be submitted online via the abstract submission system before midnight (GMT) on the extended deadline date, 29 November 2018. Abstracts received after this date will NOT be accepted. Abstracts submitted by post, fax or email will not be considered.

 

  1. All abstracts should be written, submitted and presented in English.

 

  1. Abstract may have a maximum word count of 250 words (not including the abstract title, authors and institutions).

 

  1. Authors will be notified in writing by January 2019 as to whether or not their abstract has been accepted for poster presentation. The decision of the SOC is final and no correspondence will be entered into.

 

  1. Abstracts accepted and presented at the congress will be published, subject to editorial review, in the congress Final Programme book.

 

  1. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. Non-registered authors may be excluded from publication in the congress Final Programme book.

 

  1. Instructions for poster presentations will be available on the congress website.

 

  1. All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author, if different.

ABSTRACT SUBMISSION RULES

  1. Abstract submitters should ensure that the version sent is the final one; changes will not be permitted once the deadline has passed.

 

  1. Institution information should be provided for all authors. Please include institution, city and country, but exclude department, division, laboratory, etc.

 

  1. Authors are required to submit the abstract under one of the congress abstract topics. The abstract topics for the congress are:

Basic Science
Clinical Neurophysiology
Comorbidities
Drug Therapy
Education
Epidemiology
Epilepsy in the Elderly
Epilepsy Surgery
Genetics
Neuroimaging
Neuropsychology/Psychiatry
Neurostimulation
Paediatric Epileptology
Social Issues/Nursing
Status Epilepticus
Terminology and Classification
Women’s Issues

 

    1. Abstracts should be structured in 4 sections as follows:
Purpose: Indicate the objectives of the work being presented.
Method: Describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.
Results: Summarize the main findings. Wherever possible, give numerical values and statistical significance or confidence intervals.
Conclusion: State briefly the conclusions reached in the work.
  1. Figures, tables and other illustrations cannot be included.

 

  1. If the work was supported by funds provided by a commercial organization this should be stated in a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.

 

  1. Multiple submissions of abstracts describing different components of the same study are not appropriate. All findings generated from the same study should be included in a single abstract.

 

  1. Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.

 

  1. Abstracts containing data considered to be insufficiently informative will not be accepted.

 

  1. Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.

 

  1. For intervention studies (for example, therapeutic trials), the type of design (prospective or retrospective, controlled or uncontrolled, randomized or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.

 

  1. Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.

 

  1. Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.

 

  1. References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al” followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (i.e. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (i.e. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).

 

  1. Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.

ABSTRACT CONTENT RULES

ABSTRACT SUBMISSION

Can I make changes to my abstract after submission?

You can make changes to the abstract, even if the abstract has been submitted, up to the abstract submission deadline. Please contact emec@epilepsycongress.org.

Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study; in this case only after the deadline please contact emec@epilepsycongress.org.

 

Can I submit an abstract after the deadline?

Late abstracts may be accepted, and will be handled on a case-by-case basis.

 

Can an Encore Abstract be submitted?

Yes an Encore Abstract can be submitted providing that there is no copyright issue with the original publisher.

ABSTRACT ACCEPTANCE

When will I know if my abstract has been accepted?

Authors will be notified of the outcome of the abstract review by January 2019.

 

How will I receive the information from the Congress Secretariat?

Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.

All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author, if different.

 

How will my abstract be presented at the congress?

Abstracts are accepted for poster presentations.

 

My colleague has received confirmation of his/her abstract acceptance and I did not, is there something wrong?

There may be a problem with your email address, therefore please contact emec@epilepsycongress.org.

ABSTRACTS - ONSITE INFORMATION

Will e-posters be available at the congress?

E-posters are not available at the congress.

 

Do posters have to stay up for the duration of the congress?

See all information relating to posters here.

 

Can I include videos beside my poster?

AV equipment is not provided by the congress. If you wish to order any specific equipment to complement your poster, please contact the Congress Secretariat in order to receive a quotation.

ABSTRACTS - GENERAL QUERIES

Which reference number should I use when I send a query to the Congress Secretariat?

The reference number sent to you by the Congress Secretariat with the acknowledgement of your abstract submission should be mentioned in all correspondence.

 

I am not the first author; can I present the poster on behalf of my colleagues?

Presentation by a second author may be allowed. Once your registration has been completed, please contact emec@epilepsycongress.org.

 

Can the presenting author pay one day registration fee (for that day when the poster is displayed)?

No. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. An abstract presenter may not register as a day delegate. Non-registered authors may be excluded from publication in the congress Final Programme book.

 

I am a speaker in the congress programme; do I need to submit an abstract?

Speakers are not required to submit abstracts to illustrate their talks.

 

How do I find out information about the posters?

See all information relating to posters here.

FREQUENTLY ASKED QUESTIONS

Poster Presentation Guidelines

View and download the poster presentation guidelines.

 

Poster Display Dates:

Posters will be on display on Friday, 8 March and Saturday, 9 March.

Presenters must be at their posters from 13.00 to 14.00.

 

Set Up and Removal Times:

Posters must be set up between 08.30 and 09.00 on Friday, 8 March. Materials to affix your poster will be provided.

Posters may only be taken down between 17.30 and 18.00 on Saturday, 9 March

The congress will not be held responsible for any posters that are left behind.

 

Poster Board Size:

The maximum available dimensions for posters are as follows: 90cm wide x 150cm high (portrait orientation).

It is not compulsory to use the whole of the poster board but a minimum poster size of A1 portrait (59cm wide x 84cm high) is recommended.

Remember, if the poster fills the whole of the poster board, delegates may find it difficult to read what is at the bottom of the poster.

Any posters that overlap an adjoining board will be removed.

 

Poster Number (P Number):

All poster presenters will receive a poster number e.g. p044. This will be used on-site for the poster board number. This poster number will also be referenced in the Final Programme, where the title of the abstracts and the authors’ details will be mentioned.

 

The abstracts will be available on the congress website.

 

For any queries, please contact the Congress Secretariat at emec@epilepsycongress.org.

POSTER INFORMATION